Lee's Pharmaceutical Holdings Limited (HKG:0950)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.120
-0.030 (-2.61%)
Apr 29, 2026, 4:08 PM HKT
-15.79%
Market Cap 677.16M
Revenue (ttm) 1.44B
Net Income (ttm) 91.94M
Shares Out 588.84M
EPS (ttm) 0.16
PE Ratio 7.37
Forward PE n/a
Dividend 0.05 (3.91%)
Ex-Dividend Date May 27, 2026
Volume 3,058,500
Average Volume 758,825
Open 1.150
Previous Close 1.150
Day's Range 1.090 - 1.180
52-Week Range 1.090 - 2.700
Beta 0.58
RSI 34.04
Earnings Date Mar 30, 2026

About HKG:0950

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea... [Read more]

Sector Healthcare
Founded 1994
Employees 1,036
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0950
Full Company Profile

Financial Performance

In 2025, HKG:0950's revenue was 1.44 billion, an increase of 2.57% compared to the previous year's 1.40 billion. Earnings were 91.94 million, a decrease of -1.25%.

Financial Statements

News

There is no news available yet.